Ventricular Assist Devices Market Size & Share Report, 2034

Ventricular Assist Devices Market - By Product, By Application, By Patient, By Flow, By Design, By End Use - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/Country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Product trends

2.2.3&nbsp;&nbsp;&nbsp; Application trends

2.2.4&nbsp;&nbsp;&nbsp; Patient trends

2.2.5&nbsp;&nbsp;&nbsp; Flow trends

2.2.6&nbsp;&nbsp;&nbsp; Design trends

2.2.7&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increase in the number of heart failures and cardiovascular diseases

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancements

3.2.1.3&nbsp;&nbsp;&nbsp; Rise in awareness regarding heart failure treatment

3.2.1.4&nbsp;&nbsp;&nbsp; Shortage of heart donors

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of devices

3.2.2.2&nbsp;&nbsp;&nbsp; Surgical risks and complications

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Adoption in emerging markets

3.2.3.2&nbsp;&nbsp;&nbsp; Growing demand for patient-friendly solutions

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.5&nbsp;&nbsp;&nbsp; Technological landscape

3.5.1&nbsp;&nbsp;&nbsp; Current technologies

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.8&nbsp;&nbsp;&nbsp; Global heart transplantation scenario

3.9&nbsp;&nbsp;&nbsp; Epidemiology landscape

3.10&nbsp;&nbsp;&nbsp; Pipeline analysis

3.11&nbsp;&nbsp;&nbsp; Investment landscape

3.12&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.13&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.14&nbsp;&nbsp;&nbsp; PESTEL analysis

3.15&nbsp;&nbsp;&nbsp; Gap analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.3.1&nbsp;&nbsp;&nbsp; North America

4.3.2&nbsp;&nbsp;&nbsp; Europe

4.3.3&nbsp;&nbsp;&nbsp; Asia Pacific

4.3.4&nbsp;&nbsp;&nbsp; LAMEA

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn, Units)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Left ventricular assist devices (LVADs)

5.3&nbsp;&nbsp;&nbsp; Right ventricular assist devices (RVADs)

5.4&nbsp;&nbsp;&nbsp; Biventricular assist devices (BIVADs)

5.5&nbsp;&nbsp;&nbsp; Percutaneous ventricular assist devices

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Destination therapy

6.3&nbsp;&nbsp;&nbsp; Bridge-to-candidacy (BTC) therapy

6.4&nbsp;&nbsp;&nbsp; Bridge-to-transplant (BTT) therapy

6.5&nbsp;&nbsp;&nbsp; Bridge-to-recovery (BTR) therapy

6.6&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Patient, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Adults

7.3&nbsp;&nbsp;&nbsp; Pediatrics

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Flow, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Pulsatile flow

8.3&nbsp;&nbsp;&nbsp; Continuous flow

8.3.1&nbsp;&nbsp;&nbsp; Axial continuous flow

8.3.2&nbsp;&nbsp;&nbsp; Centrifugal continuous flow

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Design, 2021 - 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Transcutaneous

9.3&nbsp;&nbsp;&nbsp; Implantable

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; Hospitals

10.3&nbsp;&nbsp;&nbsp; Cardiac catheterization labs

10.4&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

10.5&nbsp;&nbsp;&nbsp; Other end use

Chapter 11&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

11.1&nbsp;&nbsp;&nbsp; Key trends

11.2&nbsp;&nbsp;&nbsp; North America

11.2.1&nbsp;&nbsp;&nbsp;U.S.

11.2.2&nbsp;&nbsp;&nbsp;Canada

11.3&nbsp;&nbsp;&nbsp; Europe

11.3.1&nbsp;&nbsp;&nbsp;Germany

11.3.2&nbsp;&nbsp;&nbsp;UK

11.3.3&nbsp;&nbsp;&nbsp;France

11.3.4&nbsp;&nbsp;&nbsp;Spain

11.3.5&nbsp;&nbsp;&nbsp;Italy

11.3.6&nbsp;&nbsp;&nbsp;Netherlands

11.4&nbsp;&nbsp;&nbsp; Asia Pacific

11.4.1&nbsp;&nbsp;&nbsp;China

11.4.2&nbsp;&nbsp;&nbsp;Japan

11.4.3&nbsp;&nbsp;&nbsp;India

11.4.4&nbsp;&nbsp;&nbsp;Australia

11.4.5&nbsp;&nbsp;&nbsp;South Korea

11.5&nbsp;&nbsp;&nbsp; Latin America

11.5.1&nbsp;&nbsp;&nbsp;Brazil

11.5.2&nbsp;&nbsp;&nbsp;Mexico

11.5.3&nbsp;&nbsp;&nbsp;Argentina

11.6&nbsp;&nbsp;&nbsp; Middle East and Africa

11.6.1&nbsp;&nbsp;&nbsp;South Africa

11.6.2&nbsp;&nbsp;&nbsp;Saudi Arabia

11.6.3&nbsp;&nbsp;&nbsp;UAE

Chapter 12&nbsp;&nbsp;&nbsp;Company Profiles 

12.1&nbsp;&nbsp;&nbsp; Abbott

12.2&nbsp;&nbsp;&nbsp; Berlin Heart

12.3&nbsp;&nbsp;&nbsp; BrioHealth

12.4&nbsp;&nbsp;&nbsp; CorWave

12.5&nbsp;&nbsp;&nbsp; EVAHEART

12.6&nbsp;&nbsp;&nbsp; Jarvik HEART

12.7&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson

&nbsp;&nbsp;&nbsp;

Ventricular Assist Devices Market

Get a free sample of this report